Abstract
This narrative review outlines the work done in other fields with regards biomarker validation and qualification and the lessons that we may learn from this experience. Defining a universally agreed upon path for biomarker validation and qualification is urgently needed to circumvent many of the hurdles faced in OA therapeutic development irrespective of whether we are discussing biochemical markers, imaging markers or other measures. This review proposes a path that may be suitable for osteoarthritis and poses some logical next steps that will take us in this direction.
Keywords: Osteoarthritis, biomarkers, imaging, biochemical marker, validation, qualification, intervention, surrogate
Current Drug Targets
Title: A Pathway and Approach to Biomarker Validation and Qualification for Osteoarthritis Clinical Trials
Volume: 11 Issue: 5
Author(s): David J. Hunter, Elena Losina, Ali Guermazi, Deb Burstein, Marissa N. Lassere and Virginia Kraus
Affiliation:
Keywords: Osteoarthritis, biomarkers, imaging, biochemical marker, validation, qualification, intervention, surrogate
Abstract: This narrative review outlines the work done in other fields with regards biomarker validation and qualification and the lessons that we may learn from this experience. Defining a universally agreed upon path for biomarker validation and qualification is urgently needed to circumvent many of the hurdles faced in OA therapeutic development irrespective of whether we are discussing biochemical markers, imaging markers or other measures. This review proposes a path that may be suitable for osteoarthritis and poses some logical next steps that will take us in this direction.
Export Options
About this article
Cite this article as:
J. Hunter David, Losina Elena, Guermazi Ali, Burstein Deb, N. Lassere Marissa and Kraus Virginia, A Pathway and Approach to Biomarker Validation and Qualification for Osteoarthritis Clinical Trials, Current Drug Targets 2010; 11 (5) . https://dx.doi.org/10.2174/138945010791011947
DOI https://dx.doi.org/10.2174/138945010791011947 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protein Tyrosine Nitration: Role in Aging
Current Aging Science Selective Agents for Serotonin2C (5-HT2C) Receptor
Current Topics in Medicinal Chemistry Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets Preface
Current Drug Research Reviews IgE-Mediated Disorders: Current Therapeutics and New Strategies Involving Synthetic Peptides
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cardiovascular Diseases and the Nitric Oxide Pathway
Current Vascular Pharmacology Editorial: Drug Targets and Biomarkers for Obstetric/Gynecologic/Reproductive Diseases
Current Drug Targets IAPs, their Antagonists and their Role in Neurological Disease and Cancer
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Basic Mechanisms of Augmentation of Antidepressant Effects with Thyroid Hormone
Current Drug Targets Understanding the Structural Basis of ALDH-2 Inhibition by Molecular Docking
Medicinal Chemistry Recent Developments in the Discovery of Novel Antipsychotic Agents Modualating Dopamine and Serotonin Receptors
Current Drug Targets HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Meta-analysis of Native Studies as Regards the Effectiveness of Antidepressants on Deficit Syndrome of Schizophrenia: A Systematic Review
Current Psychopharmacology Interaction of Calreticulin with Amyloid Beta Peptide 1-42
Protein & Peptide Letters Perspectives in Medicinal Chemistry: Metallomics and New Targets in Metal-Based Drug Discovery
Current Topics in Medicinal Chemistry Sildenafil is Well Tolerated by Erectile Dysfunction Patients Taking Antihypertensive Medications, Including Those on Multidrug Regimens
Current Drug Safety Modulation of Microglial Innate Immunity in Alzheimers Disease by Activation of Peroxisome Proliferator-activated Receptor Gamma
Current Medicinal Chemistry Comparison of the Effects of Contralaterally Controlled Functional Electrical Stimulation and Neuromuscular Electrical Stimulation on Upper Extremity Functions in Patients with Stroke
CNS & Neurological Disorders - Drug Targets A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities
Current Drug Targets Calpain as a Potential Therapeutic Target in Parkinsons Disease
CNS & Neurological Disorders - Drug Targets